NHS National Framework Agreement for the emergency supply of Generic Pharmaceuticals - Co-Amoxiclav powder for solution (for DLN and DNW Regions only)
key details
| Value | £1,400,000 |
|---|---|
| Status | complete |
| Category (CPV) | 33690000 |
| Region | North West, East of England, London |
| Deadline | 12 Jun 2015 |
| Contract start | 24 Aug 2015 |
| Contract end | 30 Jun 2016 |
| SME suitable | Yes |
| OCID | ocds-b5fd17-a24157d5-adc8-11e6-9901-0019b9f3037b |
Award
| Supplier | Value | Date | Status |
|---|---|---|---|
| GlaxoSmithKline UK Limited | £0 | 17 Jun 2015 | active |
description
NHS Framework for the emergency supply of Generic Pharmaceuticals - Co-Amoxiclav powder for solution.
Period of framework agreement - 24/08/2015 to 30/06/2016
Regions - DLN and DNW
Additional information: The previous contractor terminated their agreement indicating an inability to supply. This tender sought to put in place arrangements to assure continuity of supply of this medicine.
The value of the framework agreement will be in the range of £1,150,000 and £1,400,000
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 3 Aug 2015 | Award (award) | · | ocds-b5fd17-a24157d5-adc8-11e6-9901-0019b9f3037b-70631-cm-phg-15-5468 |
more from COMMERCIAL MEDICINES UNIT
- NHS National Framework Agreement for the supply of Nitric Oxide Therapy. To include the supply of gas, rental of cylinders and delivery equipment, maintenance and consumables · £22,000,000 · 17 Aug 2018
- NHS National Framework Agreement for the supply of Recombinant Factor IX products for the treatment of bleeding disorders · £50,600,000 · 17 Aug 2018
- NHS National Framework Agreement for the supply of Human Cell Line Recombinant Factor VIII products · £4,125,000 · 17 Aug 2018
- NHS Framework Agreement for Branded Pharmaceuticals - North of England Tranche A. · £575,675,600 · 24 Apr 2017
- NHS Framework Agreement for the Midlands and East Pharmacy Purchasing Group for the supply of Proprietary Pharmaceuticals - Tranche B · £102,379,487 · 24 Apr 2017
- National Framework Agreement for the Supply of Immunoglobulin · £647,709,424 · 27 Mar 2017
- Contract for the supply of BCG vaccine · 9 Jan 2017
- Invitation to offer for NHS National Framework Agreement for the supply of Human Albumin and Human Anti-D Immunoglobulin · £19,539,253 · 23 Dec 2016
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Labs Consumables ePunchout 3 · UNIVERSITY OF SOUTHAMPTON · £1,500,000
- Supply of reagents · NEWCASTLE UNIVERSITY · £177,420
- Supply of reagents · NEWCASTLE UNIVERSITY · £37,829
- Supply of reagents · NEWCASTLE UNIVERSITY · £36,485
- Supply of Antibodies · NEWCASTLE UNIVERSITY · £23,108
- Suplly of Reagents · NEWCASTLE UNIVERSITY · £23,212
- Controlled drugs · London Ambulance Service NHS Trust · £154,225
- IonOptix cardiomyocyte fluo-3 calcium and contractility acquisition system. · UNIVERSITY OF NOTTINGHAM (THE) · £67,737
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.